Related Experiment Video
Updated: Nov 17, 2025

Author Spotlight: Developing Innovative Therapeutic Strategies for Hemorrhagic Shock Research
Published on: March 22, 2024
Influence of age and shock severity on short-term survival in patients with cardiogenic shock
Jacob C Jentzer1,2, Benedikt Schrage3,4, David R Holmes1
1Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Insights
Older patients with cardiogenic shock (CS) have lower survival rates, even with similar shock severity. Advanced age and higher shock stage significantly increase mortality risk in CS patients.
Area of Science:
- Cardiology
- Geriatric Medicine
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is a critical condition with high mortality, particularly in older adults.
- The impact of age on CS outcomes is debated, with uncertainty regarding the role of shock severity.
Purpose of the Study:
- To investigate the association between patient age and cardiogenic shock severity.
- To determine the impact of age and shock severity on 30-day mortality in CS patients.
Main Methods:
- Retrospective analysis of 1749 CS patients from two centers (Mayo Clinic and University Clinic Hamburg).
- Shock severity was classified using the Society for Cardiovascular Angiography and Intervention (SCAI) shock stages.
- Cox proportional-hazards analysis was used to identify predictors of 30-day survival.
Main Results:
- Older CS patients exhibited similar shock severity but had more comorbidities and worse renal function.
- Thirty-day survival was 53.3% overall and decreased significantly with increasing age and SCAI shock stage.
- Adjusted 30-day survival was incrementally lower in older age groups compared to those under 50.
Conclusions:
- Older patients with CS face lower short-term survival despite comparable shock severity.
- Increasing age and more severe shock (SCAI stages) are independently associated with higher mortality risk.
- Optimal treatment strategies for elderly CS patients require further investigation.
Aims:
Cardiogenic shock (CS) is associated with poor outcomes in older patients, but it remains unclear if this is due to higher shock severity. We sought to determine the associations between age and shock severity on mortality among patients with CS.
Methods And Results:
Patients with a diagnosis of CS from Mayo Clinic (2007-15) and University Clinic Hamburg (2009-17) were subdivided by age. Shock severity was graded using the Society for Cardiovascular Angiography and Intervention (SCAI) shock stages. Predictors of 30-day survival were determined using Cox proportional-hazards analysis. We included 1749 patients (934 from Mayo Clinic and 815 from University Clinic Hamburg), with a mean age of 67.6 ± 14.6 years, including 33.6% females. Acute coronary syndrome was the cause of CS in 54.0%. The distribution of SCAI shock stages was 24.1%; C, 28.0%; D, 33.2%; and E, 14.8%. Older patients had similar overall shock severity, more co-morbidities, worse kidney function, and decreased use of mechanical circulatory support compared to younger patients. Overall 30-day survival was 53.3% and progressively decreased as age or SCAI shock stage increased, with a clear gradient towards lower 30-day survival as a function of increasing age and SCAI shock stage. Progressively older age groups had incrementally lower adjusted 30-day survival than patients aged <50 years.
Conclusion:
Older patients with CS have lower short-term survival, despite similar shock severity, with a high risk of death in older patients with more severe shock. Further research is needed to determine the optimal treatment strategies for older CS patients.
More Related Videos
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

